HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Sorensen, S. G. Articles by O'Rourke, R. A. Search for Related Content PubMed PubMed Citation Articles by Sorensen, S. G. Articles by O'Rourke, R. A.

Noninvasive Quantitation of Right-Ventricular Volume Overload in Adults by Gated Equilibrium Radionuclide Angiography

Audie Murphy Veterans Administration Hospital, and The University of Texas Health Science Center, San Antonio, Texas

Correspondence: For reprints contact: Sherman G. Sorensen, MD, Dept. of Med./Cardiol University of Texas Health Science Center, 7703 Floyd Curl Dr., San Antonio, TX 78284.

ABSTRACT

R-wave-synchronized equilibrium radionuclide angiography (RNA) is a noninvasive method whose time-activity curves provide count information that is proportional to ventricular volume. We have performed resting gated RNA in nine consecutive adult patients undergoing cardiac catheterization for evaluation of left-to-right shunting. Pulmonary/systemic flow ratios (Qp/Qs) calculated from RNA correlated well with Qp/Qs defined by oximetry (r = 0.87, y = 0.85x + 0.11, sy·x = 0.46). In five patients imaged before, and within 1 mo after, successful surgical repair, RNA Qp/Qs declined from a mean (±s.d.) of 2.9 ± 1.0 to 1.1 ± 0.2. Right/left ventricular end-diastolic volume ratios declined from 3.1 ± 1.3 to 1.7 ± 0.2. Although left-ventricular ejection fraction did not change, right-ventricular ejection fraction declined in these patients. Imaging in nine patients with right-ventricular dysfunction, but without shunt or regurgitation, yielded a mean Qp/Qs of 0.94 ± 0.27. We conclude that Qp/Qs, right-ventricular ejection fraction, and relative ventricular enlargement may be accurately quantitated and followed serially after therapeutic intervention using gated RNA.